Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.
This registered study examines “Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.” The registry entry describes the research question and study protocol; it does not show that the intervention is safe or effective. Review the linked ClinicalTrials.gov record for the current study phase, enrollment criteria, endpoints, locations, recruitment status and any posted results.
Open original source ↗Collected Nov 9, 2026. Third-party data may change. Consult the original publication or registry for complete methods, findings and status.